Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia [6]

New England Journal of Medicine

Volumn 343, Issue 7, 2000, Pages 515-

  Pötzsch, Bernd ^a   Klövekorn, Wolf Peter ^b   Madlener, Katharina ^b  

^a UNIVERSITY OF BONN   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID; DRUG ANTIBODY; HEPARIN; HIRUDIN; THROMBOCYTE FACTOR 4;

ANTICOAGULATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DRUG INDUCED DISEASE; HEPARINIZATION; HUMAN; LETTER; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ANTIBODIES; ANTICOAGULANTS; CORONARY ARTERY BYPASS; HEPARIN; HUMANS; THROMBOCYTOPENIA;

EID: 0034680004     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200008173430718     Document Type: Letter

References (0)